The ORIGIN consortium met on 15 June 2026 to begin a four-year collaboration focused on transforming how high-value natural ingredients are discovered and produced. The project brings together seven partners from Portugal, Denmark, Spain, the United Kingdom, Switzerland and the Netherlands, coordinated by SilicoLife.
ORIGIN will develop a digitally integrated bioproduction platform connecting large-scale microbial bioprospecting, AI-driven pathway and enzyme design, multi-host strain engineering, fermentation scale-up, and economic, safety, sustainability and regulatory assessment.
Pipeline targets
- 50 molecules with pathway blueprints
- 10 lead microbial strains selected
- 3 processes demonstrated at pilot scale
During the kick-off, partners aligned the seven work packages, interfaces between digital and experimental activities, data and governance principles, impact planning and the NOVA-led Citizen Science initiative.
The meeting marked the start of a shared effort to accelerate biotechnology while supporting biodiversity protection, more resilient ingredient supply chains and responsible public engagement.
